These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

883 related articles for article (PubMed ID: 2420891)

  • 1. Enhanced lysis of herpes simplex virus type 1-infected mouse cell lines by NC and NK effectors.
    Colmenares C; Lopez C
    J Immunol; 1986 May; 136(9):3473-80. PubMed ID: 2420891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High cytotoxic activity against herpes simplex virus type 1 infected targets found in murine peritoneum.
    Brownridge E; Lopez C
    Nat Immun Cell Growth Regul; 1986; 5(6):294-304. PubMed ID: 2432414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural killer cellular cytotoxicity against herpes simplex virus-infected cells in Igh-1-disparate mice.
    Tamesis RR; Foster CS
    Invest Ophthalmol Vis Sci; 1990 Nov; 31(11):2224-9. PubMed ID: 1700771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural cytotoxicity against mouse hepatitis virus-infected target cells. I. Correlation of cytotoxicity with virus binding to leukocytes.
    Holmes KV; Welsh RM; Haspel MV
    J Immunol; 1986 Feb; 136(4):1446-53. PubMed ID: 3003198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positively selected Leu-11a (CD16+) cells require the presence of accessory cells or factors for the lysis of herpes simplex virus-infected fibroblasts but not herpes simplex virus-infected Raji.
    Fitzgerald-Bocarsly P; Feldman M; Curl S; Schnell J; Denny T
    J Immunol; 1989 Aug; 143(4):1318-26. PubMed ID: 2526183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of susceptibility of HSV-1-infected cells to natural killer lysis by interferon.
    Muñoz A; Carrasco L; Fresno M
    J Immunol; 1983 Aug; 131(2):783-7. PubMed ID: 6190939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of natural killer cells and interferon in resistance to acute infection of mice with herpes simplex virus type 1.
    Bukowski JF; Welsh RM
    J Immunol; 1986 May; 136(9):3481-5. PubMed ID: 2420892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human natural killer cell recognition of herpes simplex virus type 1 glycoproteins: specificity analysis with the use of monoclonal antibodies and antigenic variants.
    Bishop GA; Marlin SD; Schwartz SA; Glorioso JC
    J Immunol; 1984 Oct; 133(4):2206-14. PubMed ID: 6206157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purification and target cell range of in vivo elicited blast natural killer cells.
    Biron CA; Pedersen KF; Welsh RM
    J Immunol; 1986 Jul; 137(2):463-71. PubMed ID: 3722814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. I. Lysis restricted by HLA class II MB and DR antigens.
    Yasukawa M; Zarling JM
    J Immunol; 1984 Jul; 133(1):422-7. PubMed ID: 6609990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of interferon in natural kill of HSV-1-infected fibroblasts.
    Fitzgerald PA; von Wussow P; Lopez C
    J Immunol; 1982 Aug; 129(2):819-23. PubMed ID: 6177785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inability of interferon to protect virus-infected cells against lysis by natural killer (NK) cells correlates with NK cell-mediated antiviral effects in vivo.
    Bukowski JF; Welsh RM
    J Immunol; 1985 Nov; 135(5):3537-41. PubMed ID: 2413125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural killer cells in mouse lung: surface phenotype, target preference, and response to local influenza virus infection.
    Stein-Streilein J; Bennett M; Mann D; Kumar V
    J Immunol; 1983 Dec; 131(6):2699-704. PubMed ID: 6644021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Window of vulnerability of vaccinia virus-infected cells to natural killer (NK) cell-mediated cytolysis correlates with enhanced NK cell triggering and is concomitant with a decrease in H-2 class I antigen expression.
    Brutkiewicz RR; Klaus SJ; Welsh RM
    Nat Immun; 1992; 11(4):203-14. PubMed ID: 1421956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterogeneity of human NK cells: comparison of effectors that lyse HSV-1-infected fibroblasts and K562 erythroleukemia targets.
    Fitzgerald PA; Evans R; Kirkpatrick D; Lopez C
    J Immunol; 1983 Apr; 130(4):1663-7. PubMed ID: 6601135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human natural killer cells limit replication of herpes simplex virus type 1 in vitro.
    Fitzgerald PA; Mendelsohn M; Lopez C
    J Immunol; 1985 Apr; 134(4):2666-72. PubMed ID: 2982949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heteroconjugate antibodies enhance cell-mediated anti-herpes simplex virus immunity.
    Paya CV; McKean DJ; Segal DM; Schoon RA; Showalter SD; Leibson PJ
    J Immunol; 1989 Jan; 142(2):666-71. PubMed ID: 2536060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lysis of herpes simplex virus (HSV) infected targets. III. Effect of HSV on natural killer activity.
    Hendricks RL; Sugar J
    Invest Ophthalmol Vis Sci; 1985 Feb; 26(2):201-7. PubMed ID: 2579040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alternative mechanisms of natural killer cell activation during herpes simplex virus infection.
    Paya CV; Schoon RA; Leibson PJ
    J Immunol; 1990 Jun; 144(11):4370-5. PubMed ID: 2160501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of NK cells in mice following corneal infection with herpes simplex virus type-1.
    Brandt CR; Salkowski CA
    Invest Ophthalmol Vis Sci; 1992 Jan; 33(1):113-20. PubMed ID: 1370438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.